Click here for the PowerPoint presentation

Download Report

Transcript Click here for the PowerPoint presentation

Pharmacy
Quality Data
MEASURES, MEASURING AND ME
Michael Crooks, PharmD
Pharmacy Interventions Technical Lead
Alliant Quality – Georgia’s Medicare Quality
Improvement Organization
Learning Objectives
-Recall Medication-related quality measures beyond
the Medicare Star Ratings
-Recognize opportunities for pharmacists to improve
medication-related quality measures for health care
providers and organizations
-Apply basic skills in the Model for Improvement for
data collection, evaluation and change measurement to
pharmacy practice
Disclosure
I do not have (nor does any immediate family member
have) actual or potential conflict of interest, within the
last twelve months; a vested interest in or affiliation
with any corporate organization offering financial
support or grant monies for this continuing education
activity; or any affiliation with an organization whose
philosophy could potentially bias my presentation.
Source: CMS Physician Quality Reporting Strategic Vision – Final Draft 2015
Health Care Quality Defined
Institute of Medicine: “safe, effective,
patient-centered, timely, efficient and
equitable.”
Agency for Healthcare Research and Quality:
“as doing the right thing for the right patient,
at the right time, in the right way to achieve
the best possible results.”
Source: NCQA (National Committee for Quality Assurance) Essential Guide to
Health Care Quality. 2007
CMS Physician Quality
Reporting Strategic Vision
PAY FOR
PERFORMANCE
BETTER
QUALITY
Source: CMS Physician Quality Reporting Strategic Vision – Final Draft 2015
Health Care Quality
Measurement
Systematic: standardized
Rigorous: reliable, validated, evidencebased and supported by expert consensus
Quantifiable: compare results against a
reference, standard or benchmark
Source: NCQA (National Committee for Quality Assurance) Essential Guide to
Health Care Quality. 2007
Health Care Quality Measures
Process: Was something done? Lab test, timely
referral, RX prescribed
Outcomes: Did the patient benefit? Resolution
of symptom, avoided complication
Experience: Is the patient/caregiver satisfied?
Surveys, discharge questionnaires
Source: NCQA (National Committee for Quality Assurance) Essential Guide to
Health Care Quality. 2007
Medication-Related Quality
Measures
Medicare Part D Star Ratings and Pharmacy
Quality Alliance
Measures Adopted from Quality Standards
Organizations
Internal Quality Measurement
Learn more at
PQAalliance.org
5 Measures of
appropriate
medication use.
Almost half of
Rating Score
(13 out of 30.5)
Source:”PQA Measures Used By CMS in the Star Ratings” Pharmacy Quality Alliance.
http://pqaalliance.org/measures/cms.asp. Web March 25, 2016
5 other
measures that
pharmacists can
impact.
Another 36% of
Ratings Score
(11 out of 30.5)
Total is 79%
Source:”PQA Measures Used By CMS in the Star Ratings” Pharmacy Quality Alliance.
http://pqaalliance.org/measures/cms.asp. Web March 25, 2016
Other PQA Measures – Medicare
Advantage Plan Quality Measures:
Annual Influenza vaccination
Glucose and cholesterol control in diabetes
patients
Blood pressure control
Osteoporosis management in women who have
had fractures
Rheumatoid arthritis management
Cholesterol screening
Source: ”Pharmacists’ Stellar Experience Can Create Five-Star Success”
The Consultant Pharmacist.. Vol 29, No 12. pp788-796. Dec 2014
Other PQA Measures – Display
Measures
Use of Benzodiazepine Sedative Hypnotic Medications
in the Elderly
◦ % of 65+ year olds that received 2+ prescription fills for any
benzodiazepine sedative hypnotic for 90+ cumulative days
Use of Opioids at High Dosage in Persons Without
Cancer
◦ The proportion of non-cancer, adult patients receiving a daily
dosage of opioids greater than 120mg morphine equivalent
dose (MED) for 90 consecutive days or longer.
Source:”PQA Measures Used By CMS in the Star Ratings” Pharmacy Quality Alliance.
http://pqaalliance.org/measures/cms.asp. Web March 25, 2016
Defining the Population of Focus
All Pharmacy
Patients
Patient Criteria 1
Patient Criteria 2
Population of Focus
Denominator
Condition
Outcome Measure
Denominator
Numerator
condition
Outcome Measure
Numerator
Defining the Population of Focus
Example: High-Dose
Opioid use in noncancer patients
Population of Focus
Have 2+ meds, filled
over ≥150 days; no
oncology meds
Outcome Measure
Denominator
Outcome Measure
Numerator
Quality Standards
Organizations and Measures
HEDIS: Health Effectiveness Data and Information
Set
◦ Health plan quality measures derived from insurance claims,
applicable to Commercial, Medicaid and Medicare plans
VBM: Value-Based Modifier
◦ Payment adjustment for physicians based on performance
measures in the Physician Quality Reporting System (PQRS)
HRRP: Hospital Readmission Reduction Program
◦ Payment reduction (penalty) to hospitals for ‘excessive’
readmission rates
Pharmacy Quality Improvement
Opportunities: HEDIS
Annual monitoring for patients using ACE-I/ARB
◦ % of patients using ACE-I/ARB for ≥180 days who have lab
measures for K+ and CrCl within the year
Flu vaccinations for adults 18-64
◦ % of patients in the age range responding “yes” to the
survey question “Have you had a flu shot since July 1 of
2015?”
Medication Management for patients with Asthma
◦ % of patients 5 to 64 with persistent asthma with ≥75%
proportion of days covered with asthma controller
medications
Source: “Quality Rating System, Measure Technical Specifications” CMS.
https://www.cms.gov/Medicare/Quality-Initiatives-Patient-AssessmentInstruments/QualityInitiativesGenInfo/Downloads/2016-QRS-Measure-TechnicalSpecifications.pdf. Web March 25, 2016
Defining the Population of Focus
All Pharmacy
Patients
Patients 18 and
over
Example: Lab
monitoring for
Persistent
ACE-I/ARB Use
Patients Using
ACE-I/ARB
for≥180 days
Population of Focus
18+ w/claim
for ACE-I/ARB
for≥180 days
Outcome Measure
Denominator
Completed
Labs for K+
and CrCl
Outcome Measure
Numerator
Pharmacy Quality Improvement
Opportunities: VBM and PQRS
PQRS #001: Medication Reconciliation
◦ % of patients ≥18 years discharged from inpatient facility who
are seen within 30 days with documented medication
reconciliation of discharge medication orders and current
medication list
PQRS #111: Pneumococcal Vaccination Status for Older
Adults
◦ % of patients 65 years who have ever received a
pneumococcal vaccination
Source: “2015 Cross-Cutting Measures List ” CMS.
https://www.cms.gov/Medicare/Quality-Initiatives-Patient-AssessmentInstruments/PQRS/Downloads/2015_PQRS_CrosscuttingMeasures
_12172014.pdf. Web March 25, 2016
Defining the Population of Focus
All Pharmacy
Patients
Medicare patient
18 and over
Discharged from
inpatient facility
Patients referred
to your care transitions program
Seen w/in 30
days and Med
Rec
Documented
Example: PQRS Medication
Reconciliation
Population of Focus
Outcome Measure
Denominator
Outcome Measure
Numerator
Pharmacy Quality Improvement
Opportunities: Internal Quality
Measurement
Self-measurement of validated measures
Other outcomes, process or experience
measures
Pharmacy workflow measures
Pharmacy business/financial measures
Activity: Designing a Pharmacy
Quality Improvement Measure
Work in groups to decide on a quality improvement
measure and complete a Population of Focus
worksheet
3 minutes to complete
Report out from your group:
What are you trying to accomplish
How will you know a change is an improvement
What change can you make that will result in improvement
Activity: Designing a Pharmacy
Quality Improvement Measure
Work in groups to decide on a quality improvement
measure and complete a Population of Focus
worksheet
3 minutes to complete
Consider a measure important to you:
Business:
% Children’s liquid meds upsold w/flavoring
% days on hand >35 days for Rx stock valued $500
Patient Care: % patients with diabetes on ACE-I/ARB
% opioid patients with control Rx from 4+ MDs
Workflow: % filled Rx returned to stock
Defining the Population of Focus
All Pharmacy
Patients
Patient Criteria 1
Patient Criteria
2
Population of Focus
Denominator
Condition
Outcome Measure
Denominator
Numerator
condition
Outcome Measure
Numerator
Model For Improvement
Activity: Designing a Pharmacy
Quality Improvement Plan
Now that you’ve decided on a measure, consider:
What factors have a negative influence on the rate?
Which is most significant and what are the root causes?
What can you do to change this root cause?
Report out from your group:
What are you trying to accomplish?
What change can you make that will result in improvement?
How will you know a change is an improvement – what data
can you measure?
PDSA Cycle for Process
Improvement
ACT
 What changes are to be
made?
 Next cycle – continue,
adapt or discontinue?
STUDY
 Complete the analysis of the
data
 Compare data to predictions
 Summarize what is learned
PLAN
Start
 Objective
 Questions and predictions
 Plan to carry out the cycle
(who, what, where, when)
 Plan for data collection
DO
 Carry out the plan
 Document the problems and
unexpected observations
 Begin analysis of the data
Root Cause Analysis Template
Project Flow
Define
population
and measures
Develop AIM
P
A
D
A
S
Obtain
baseline
measures
P
P
D
S
A
D
S
Set
measureable
goals
Re-measure
Re-measure
MIchael Crooks, PharmD.
Alliant Quality – Medicare QIO for Georgia
[email protected]
678-527-3601
Visit GPhAconvention.com/grow to download materials
from this and other presentations.